"10.1371_journal.pone.0071470","plos one","2013-09-06T00:00:00Z","Maitreyi Murthy; Sumithra Selvam; Nelson Jesuraj; Sean Bennett; Mark Doherty; Harleen M S Grewal; Mario Vaz; and the TB Trials Study Group","Department of Clinical Science, Infection, Faculty of Medicine and Dentistry, University of Bergen; Department of Microbiology, Haukeland University Hospital, Bergen, Norway; St. John’s Research Institute, Bangalore, Karnataka, India; Division of Epidemiology, Biostatistics and Population Health, St. John’s Research Institute, Bangalore, Karnataka, India; Infectious Disease Epidemiology, St. John’s Research Institute, Bangalore, Karnataka, India; Clinical Development, Aeras Global TB Vaccine Foundation, Rockville, Maryland, United States of America; Department of Infectious Disease Immunology, GlaxoSmithKline, Copenhagen, Denmark; Department of Clinical Science, Infection, Faculty of Medicine and Dentistry, University of Bergen and Department of Microbiology, Haukeland University Hospital, Bergen, Norway","Conceived and designed the experiments: MV HMSG MM. Performed the experiments: MM NJ SS HMSG MV. Analyzed the data: MM SS MV. Contributed reagents/materials/analysis tools: SS SB MV. Wrote the manuscript: MM MD HMSG MV. Involved in the development of the protocol of the larger study within which the present analysis is embedded as well as the implementation and quality control of the study: TBTSG. Worked as medical officer for the project and was part of the clinical data collection and supervision: MM. Principal Investigators for the project and were responsible for the conceptualization of the study question: HMSG MV.","The authors confirm that co-author Mark Doherty is a PLOS ONE Editorial Board member. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","09","Maitreyi Murthy","MM",8,TRUE,3,5,3,4,TRUE,TRUE,FALSE,0,NA,FALSE
